BiotechTube

RV5 (Pentavalent Rotavirus Vaccine)

ApprovedCompleted
1 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Diarrhea

Conditions

Diarrhea, Gastroenteritis

Trial Timeline

Feb 1, 2014 → May 1, 2016

NCT ID
NCT01960725

About RV5 (Pentavalent Rotavirus Vaccine)

RV5 (Pentavalent Rotavirus Vaccine) is a approved stage product being developed by Merck for Diarrhea. The current trial status is completed. This product is registered under clinical trial identifier NCT01960725. Target conditions include Diarrhea, Gastroenteritis.

What happened to similar drugs?

8 of 20 similar drugs in Diarrhea were approved

Approved (8) Terminated (4) Active (10)
🔄YM060 + PlaceboAstellas PharmaPhase 3
🔄Fidaxomicin oral suspension + Fidaxomicin tablets + Vancomycin oral liquid + Vancomycin capsulesAstellas PharmaPhase 3
🔄YM060Astellas PharmaPhase 3
✅loperamide-simethicone + matching placeboJohnson & JohnsonApproved
✅Loperamide/simeticone 2 mg/125 mg caplets + Loperamide/simeticone 2 mg/125 mg chewable tablets + Probiotic Saccharomyces boulardii 250 mg capsulesJohnson & JohnsonApproved
🔄fidaxomicin + PlaceboMerckPhase 3
🔄Octreotide Long Acting ReleaseNovartisPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01960725ApprovedCompleted

Competing Products

20 competing products in Diarrhea

See all competitors
ProductCompanyStageHype Score
Metronidazole + Metronidazole-DRF1 + Metronidazole-DRF2Dr. Reddy's LaboratoriesPhase 2
32
YM060 + PlaceboAstellas PharmaPhase 3
40
Fidaxomicin oral suspension + Fidaxomicin tablets + Vancomycin oral liquid + Vancomycin capsulesAstellas PharmaPhase 3
40
YM060Astellas PharmaPhase 3
40
RamosetronAstellas PharmaPre-clinical
26
Racecadotril Film-Coated Tablet (FCT) + Racecadotril CapsuleJohnson & JohnsonPhase 1
29
loperamide-simethicone + matching placeboJohnson & JohnsonApproved
43
Racecadotril + Racecadotril + Racecadotril + RacecadotrilJohnson & JohnsonPhase 1
29
Loperamide/simeticone 2 mg/125 mg caplets + Loperamide/simeticone 2 mg/125 mg chewable tablets + Probiotic Saccharomyces boulardii 250 mg capsulesJohnson & JohnsonApproved
43
fidaxomicin + PlaceboMerckPhase 3
40
Surotomycin + PlaceboMerckPhase 1
29
Surotomycin + PlaceboMerckPhase 1
29
OPT-80MerckPhase 2
35
fidaxomicinMerckPhase 2
35
LJN452 + Placebo to LJN452NovartisPhase 2
35
Octreotide Long Acting ReleaseNovartisPhase 3
40
DNK333 + PlaceboNovartisPhase 2
35
Probiotic SupplementRochePre-clinical
26
Etrasimod + Placebo + CorticosteroidsPfizerPhase 2
27
Calcium Carbonate + nelfinavir + lamivudine + loperamide + nelfinavir + lamivudine + zidovudinePfizerPhase 3
32